Clinical experience of the newborn hearing screening program at Hospital Clínico de la Universidad Católica de Chile
Main Article Content
Keywords
Hearing loss, neonatal screening, otoacoustic emissions, auditory brainstem evoked response, risk factors
Abstract
Introduction: Congenital hearing loss is one of the most common neonatal conditions, affecting 1-3 per 1,000 live births. Early detection and intervention are critical for mini- mizing its impact on language, cognitive, and socio-emotional development. Universal newborn hearing screening (UNHS) is the most effective strategy for identifying hearing loss early. Objective: To describe the results of the newborn hearing screening program at Hospital Clínico de la Universidad Católica de Chile (HCUC). Materials and Methods: A retrospective, descriptive study of live newborns screened between 2019 and 2023. Screening was conducted using the HCUC protocol. Patients who did not pass the initial screening underwent follow-up evaluations. Results: Of 7,771 live births, 7,147 newborns were scree- ned, achieving 92% coverage. Since 2020, the coverage rate has exceeded 95%. The referral rate for diagnostic evaluation was 0.78%, and the incidence of congenital hearing loss was 2.6 per 1,000 live births. Sensorineural hearing loss (SNHL) incidence was 1.8 per 1,000 live births. Among patients with SNHL, 43% had no risk factors. Conclusions: The HCUC program meets international standards for coverage and referral rates. However, challenges persist in ensuring follow-up for referred patients. Strengthening communication systems and parental education is essential to optimize outcomes and align with international qua- lity standards.